Pennsylvania medical cannabis vape recall leaves patients stranded

A widespread recall of cannabis concentrates sold for vaping at medical cannabis dispensaries in the US state of Pennsylvania has left patients with more questions than answers about who to trust.

The Pennsylvania Department of Health (DOH) Office for Medical Marijuana issued the recall in February, questioning the safety of 670 products. A local newspaper estimated the recall to affect $12m worth of products, though the paper did not explain how it reached that figure.


Benefits of subscription plans:

  • Stay informed of any legal and market change in the sector that impacts your organization
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Need help?

Contact a sales representative right now and don’t wait

Erik Galavis
+34 654 320 547
Email Erik

Pablo Sharrock
+34 722 642 678
Email Pablo